Skip to content

Press

Portfolio-Media Coverage
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
January 3, 2024 Jan 3, 2024 BioSpace
Portfolio-Media Coverage
Oral SBMA therapy shows safety and tolerability in Phase 1 trial
November 15, 2023 Nov 15, 2023 SMA News Today
Portfolio-Press Releases
BioTechnology Innovators Honored in 3rd Annual BioTech Breakthrough Awards Program
November 8, 2023 Nov 8, 2023
Portfolio-Press Releases
Nido Biosciences Presents Clinical Data Supporting the Continued Development of NIDO-361 in SBMA Patients at the 2023 International Kennedy’s Disease Patient Conference
November 5, 2023 Nov 5, 2023
Portfolio-Media Coverage
ReCode raises $50 million to support developing mRNA therapies
September 22, 2023 Sep 22, 2023 Cystic Fibrosis News Today
Portfolio-Media Coverage
ReCode Raises $260M in Series B Financing to Advance Lead Programs
September 20, 2023 Sep 20, 2023 Biospace
Portfolio-Media Coverage
ReCode raises another $50M
September 19, 2023 Sep 19, 2023 Endpoints
Portfolio-Press Releases
ReCode Therapeutics Announces Closing of Extension to Series B Financing
September 19, 2023 Sep 19, 2023
Portfolio-Media Coverage
ReCode Therapeutics Raises Additional USD50M in Series B Financing
September 19, 2023 Sep 19, 2023 FinSMEs
Portfolio-Media Coverage
NIDO-361 by Nido Biosciences for Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy): Likelihood of Approval
September 11, 2023 Sep 11, 2023 Pharmaceutical Technology